Connetics Files Suit Over Agis ANDA

Law360, New York (October 27, 2005, 12:00 AM EDT) -- Connetics Corp. has sued Israeli pharmaceutical company Agis Industries Ltd. for patent infringement after Agis filed an Abbreviated New Drug Application for Connetics’ best selling scalp treatment Olux.

The lawsuit asks that the ANDA not be considered until after the Connetics’ patents for the drug expire in 2016.

The suit says that “the defendant’s ANDA included a certification of the Act of Defendant’s purported opinion that the ‘920 patent is invalid, unenforceable, or not infringed by the submission of the Defendant’s ANDA.”

According to the complaint...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.